ASX:AN1 Anagenics (AN1) Stock Price, News & Analysis → The attacks will come for me after releasing this… (From Porter & Company) (Ad) Free AN1 Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield0.88%Price TargetN/A Stock AnalysisStock Analysis Get Anagenics alerts: Email Address Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> About AnagenicsAnagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally. It develops and sells FGF5 inhibitor formulations; over-the-counter (OTC), cosmetic antiaging, and longevity targeting products; and imports and distributes international and local skin care and wellbeing products under the Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic brand names. The company also develops, manufactures, and markets beauty and wellness brands comprising Uspa and evolis. It offers its products through various channels, including clinics, retail stores, wholesale pharmacy and spa/salons, online ecommerce, and cross border export markets. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.Read More Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> AN1 Stock News HeadlinesMarch 30, 2022 | msn.comClosing Bell: Small caps rise, unemployment falls, more people accept life’s full of ups and downsSee More Headlines Receive AN1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Anagenics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorConsumer Defensive Industry Household & Personal Products Sub-IndustryN/A Current SymbolASX:AN1 CUSIPN/A CIKN/A Webwww.anagenics.com Phone61 2 9221 6830FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,580,000.00 Net Margins-30.99% Pretax MarginN/A Return on Equity-35.76% Return on Assets-12.95% Debt Debt-to-Equity Ratio12.17 Current Ratio1.44 Quick Ratio1.15 Sales & Book Value Annual Sales$10.20 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares461,320,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.96 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMs. Karen MatthewsCEO & DirectorMr. Matthew DudekChief Financial & Governance Officer and Company SecretaryMr. Scott Mitchell GreasleyExecutive DirectorMr. Dominic BurgChief Operating OfficerDr. Graham RobertsonHead of Research & DevelopmentKey CompetitorsAsaleo CareASX:AHYBeiersdorf AktiengesellschaftOTCMKTS:BDRFYBeiersdorf AktiengesellschaftOTCMKTS:BDRFFBiologix HairOTCMKTS:BLGXBlue Moon GroupOTC:BLUMYView All CompetitorsInsidersAlexander (Sandy) BeardBought 66,133 shares on 3/11/2024Total: $992.00 ($0.02/share)Alexander (Sandy) BeardBought 463,287 shares on 3/8/2024Total: $6,949.31 ($0.02/share)Alexander (Sandy) BeardBought 245,000 shares on 3/6/2024Total: $3,675.00 ($0.02/share)Scott GreasleyBought 150,000 shares on 10/4/2023Total: $3,000.00 ($0.02/share) This page (ASX:AN1) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anagenics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Anagenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.